To include your compound in the COVID-19 Resource Center, submit it here.

I-Mab to develop Genexine's HyLeukin in China

Genexine Inc. (KOSDAQ:095700) granted I-Mab Biopharma (Shanghai, China) exclusive rights to develop

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE